In the ELIXA CVOT, lixisenatide was found to be non-inferior to standard of care plus placebo in terms of risk of the composite endpoint (cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina)13.4% in the lixisenatide group and 13.2% in the placebo group (hazard ratio, 1.02
Published online May 16, 2024
Other Effects Finally, there are rare cases of obstetric, dermatological, and autoimmune complications that are difficult to explain or whose association with energy drinks does not seem to be reliable and well explained
Cancer Cell 10 , 5164 (2006)
After that, even bacteriostatic preservation becomes unreliable
The Niacinamide Serum is great for minimizing the appearance of open pores